Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient

Autor: Romero-Laorden, N., Piñeiro-Yañez, E., Gutierrez-Pecharroman, A., Pacheco, M.I., Calvo, E., Al-Shahrour, F., Castro, E., Olmos, D.
Zdroj: In Annals of Oncology May 2017 28(5):1158-1159
Databáze: ScienceDirect